A novel ubiquitin-related genes-based signature demonstrated values in prognostic prediction, immune landscape sculpture and therapeutic options in laryngeal cancer.

Front Pharmacol · 2025 · PMC11965687 · PMID 40183093

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

With the TIDE algorithm, a slight trend of higher response to immunotherapy was predicted in the low-risk group (41% vs. 31%), but unfortunately, no significance in statistics was shown ( Supplementary Figure S7A ).

also in 2,419 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.